Rationale for perioperative anticancer treatment.

Rationale for perioperative anticancer treatment. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Rationale for perioperative anticancer treatment. Abstract Text:

F M Schabel,

Rationale for perioperative anticancer treatment. Publishing Authors By Initials

FM Schabel,

For similar cells: stem cells: neoplastic stem cells research abstracts see: cells: stem cells: neoplastic stem cells research

PUBMED ID PMID:

MEDLINE DATE:

Rationale for perioperative anticancer treatment. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Recent results in cancer research. Fortschritte de

VOLUME: 98

Page Numbers: 1-10

Journal Abbreviation: Recent Results Cancer Res.

ISSN: 0080-0015

DAY: 13

MONTH: 02

YEAR: 1985

Rationale for perioperative anticancer treatment. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 44671

Rationale for perioperative anticancer treatment. Keywords Mesh Terms:

KEYWORDS: Neoplastic Stem Cells

MESH TERMS: pathology

Chemical & Substance for Abstract: Rationale for perioperative anticancer treatment. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Rationale for perioperative anticancer treatment.

AFFILIATION:

Country: GERMANY, WEST

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Recent Results Cancer Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Rationale for perioperative anticancer treatment Related Publications

• "Compression paddle gallstone": artifact of standard radiographic accessory.
• Altered sensitivity of a hamster plasmacytoma to cytosine arabinoside (NSC-63878).
• Antiviral chemotherapy as an indicated adjunct to cancer chemotherapy.
• CT evaluation of thickened esophageal walls.
• Concepts for treatment of micrometastases developed in murine systems.
• Development of Friend leukemia virus in spleen and plasma of Swiss mice.
• Ectopic cranium: postoperative abdominal wall skull fragments.
• Effect of 1,3-bis(2-chlorethyl)-1-nitrosourea (NSC-409962) and nitrogen mustard (NSC-762) on kinetic behavior of cultured L1210 leukemic cells.
• Experimental evaluation of potential anticancer agents. VII. Cross resistance of alkylating agent-resistant neoplasms.
• Experimental evaluation of potential anticancer agents. XI. Quantitative response of the Sa180 system to deoxypyridoxine.
• Experimental evaluation of purine antagonists as anticancer agents.
• Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase (NSC-128056).
• Growth requirements and biologic characteristics of leukemia L1210 cells in culture.
• Historical development and future promise of the nitrosoureas as anticancer agents.
• Laboratory study of the epidemiology of poliomyelitis.
• Rationale for perioperative anticancer treatment.
• Recovery of poliomyelitis virus from the throat during the incubation period.
• Screening, the cornerstone of chemotherapy.
• Some observations on the carcinostatic activity of Eponate on Fortner hamster plasmacytoma.
• Spontaneous AK leukemia (lymphoma) as a model for human leukemias and lymphomas.
• Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy.
• The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis.